Mutual of America Capital Management LLC Has $2.51 Million Stock Position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Mutual of America Capital Management LLC lowered its holdings in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 4.3% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 96,179 shares of the pharmacy operator’s stock after selling 4,317 shares during the period. Mutual of America Capital Management LLC’s holdings in Walgreens Boots Alliance were worth $2,511,000 at the end of the most recent quarter.

Several other large investors have also added to or reduced their stakes in WBA. Vanguard Group Inc. grew its stake in Walgreens Boots Alliance by 14.5% during the third quarter. Vanguard Group Inc. now owns 86,675,198 shares of the pharmacy operator’s stock worth $1,927,656,000 after purchasing an additional 10,962,030 shares during the period. Moneta Group Investment Advisors LLC grew its stake in Walgreens Boots Alliance by 84,503.5% in the fourth quarter. Moneta Group Investment Advisors LLC now owns 8,325,830 shares of the pharmacy operator’s stock valued at $311,053,000 after acquiring an additional 8,315,989 shares during the period. Invesco Ltd. grew its stake in Walgreens Boots Alliance by 21.5% in the third quarter. Invesco Ltd. now owns 17,026,420 shares of the pharmacy operator’s stock valued at $378,668,000 after acquiring an additional 3,013,807 shares during the period. BlackRock Inc. grew its stake in Walgreens Boots Alliance by 4.6% in the first quarter. BlackRock Inc. now owns 63,406,129 shares of the pharmacy operator’s stock valued at $2,192,584,000 after acquiring an additional 2,797,885 shares during the period. Finally, Morgan Stanley lifted its holdings in shares of Walgreens Boots Alliance by 15.8% in the third quarter. Morgan Stanley now owns 12,584,371 shares of the pharmacy operator’s stock valued at $279,876,000 after purchasing an additional 1,720,228 shares in the last quarter. Institutional investors and hedge funds own 58.59% of the company’s stock.

Insiders Place Their Bets

In other news, CFO Manmohan Mahajan bought 6,000 shares of the firm’s stock in a transaction dated Tuesday, April 2nd. The stock was purchased at an average price of $19.38 per share, with a total value of $116,280.00. Following the transaction, the chief financial officer now owns 166,969 shares of the company’s stock, valued at $3,235,859.22. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. In other news, CFO Manmohan Mahajan bought 6,000 shares of the firm’s stock in a transaction dated Tuesday, April 2nd. The stock was purchased at an average price of $19.38 per share, with a total value of $116,280.00. Following the transaction, the chief financial officer now owns 166,969 shares of the company’s stock, valued at $3,235,859.22. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, Director Inderpal S. Bhandari bought 3,000 shares of the firm’s stock in a transaction dated Thursday, April 11th. The stock was purchased at an average cost of $18.05 per share, with a total value of $54,150.00. Following the transaction, the director now directly owns 3,000 shares in the company, valued at approximately $54,150. The disclosure for this purchase can be found here. In the last 90 days, insiders acquired 13,456 shares of company stock worth $270,423. 17.40% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

A number of analysts have issued reports on WBA shares. TD Cowen decreased their target price on Walgreens Boots Alliance from $37.00 to $35.00 and set a “buy” rating for the company in a research report on Wednesday, April 3rd. Bank of America reduced their target price on Walgreens Boots Alliance from $23.00 to $22.00 and set an “underperform” rating for the company in a research report on Tuesday, March 26th. Morgan Stanley dropped their price target on Walgreens Boots Alliance from $21.00 to $20.00 and set an “underweight” rating for the company in a research note on Monday, April 1st. Deutsche Bank Aktiengesellschaft dropped their price target on Walgreens Boots Alliance from $23.00 to $22.00 and set a “hold” rating for the company in a research note on Wednesday, April 3rd. Finally, Leerink Partnrs reaffirmed a “market perform” rating on shares of Walgreens Boots Alliance in a research note on Monday, February 26th. Four equities research analysts have rated the stock with a sell rating, ten have issued a hold rating and two have issued a buy rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Hold” and an average target price of $24.36.

Walgreens Boots Alliance Stock Up 3.7 %

Shares of WBA stock opened at $18.24 on Friday. Walgreens Boots Alliance, Inc. has a 1-year low of $17.51 and a 1-year high of $36.14. The business has a 50-day moving average of $20.42 and a 200 day moving average of $21.93. The company has a debt-to-equity ratio of 0.50, a quick ratio of 0.32 and a current ratio of 0.66.

Walgreens Boots Alliance (NASDAQ:WBA) last released its quarterly earnings data on Thursday, March 28th. The pharmacy operator reported $1.20 earnings per share for the quarter, topping the consensus estimate of $0.82 by $0.38. Walgreens Boots Alliance had a positive return on equity of 12.11% and a negative net margin of 4.18%. The business had revenue of $37.05 billion during the quarter, compared to analysts’ expectations of $35.86 billion. During the same quarter last year, the business posted $1.16 EPS. The business’s revenue was up 6.3% on a year-over-year basis. On average, equities analysts anticipate that Walgreens Boots Alliance, Inc. will post 3.23 earnings per share for the current fiscal year.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.